ARTIFICIAL INTELLIGENCE IN TACKLING CORONAVIRUS AND FUTURE PANDEMICS

Author:

Quazi ShaguftaORCID,Singh Sampa KarmakarORCID,Saha Rudra PrasadORCID,Das ArpitaORCID,Singh Manoj KumarORCID

Abstract

SARS-COV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) was initially tested in Wuhan City, China, in December 2019 and had a devastating impact worldwide, exterminating more than 6 million people as of September 2022. It became the biggest worldwide health crisis since the 1918 influenza outbreak. Viruses generally mutate randomly, so predicting how SARS-CoV-2 will transform over the next few months or years and which forms will predominate is impossible. The possibilities for virus mutation, in theory, are practically endless. Enabling researchers to determine which antibodies have the potential to be most effective against existing and future variations could help machine learning to assist in drug discovery. In the COVID-19 pandemic, AI has benefited four key areas: diagnosis, clinical decision-making for public health, virtual assistance, and therapeutic research. This study conducted a discourse analysis and textual evaluation of AI (deep learning and machine learning) concerning the COVID-19 outbreak. Further, this study also discusses the latest inventions that can be very helpful in future pandemic detection. COVID-19 has already changed our lives, and in the future, we might be able to deal with pandemics like this with the help of AI. This review has also emphasized the legal implications of AI in the battle against COVID-19.

Publisher

Journal of Experimental Biology and Agricultural Sciences

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3